CAS RN: 1231761-02-6
5-Cyanoquinazoline
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250120
100mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1231761-02-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1231761-02-6 / quinazoline-5-carbonitrile
Standard CAS: 1231761-02-6
Multi CAS: No
Basic Information
copy
CAS
1231761-02-6 copy
Multi CAS
No copy
Molecular Formula
C9H5N3 copy
Molecular Weight
155.160000 copy
Exact Mass
155.048347 copy
SMILES
C1=CC(=C2C=NC=NC2=C1)C#N copy
InChI
InChI=1S/C9H5N3/c10-4-7-2-1-3-9-8(7)5-11-6-12-9/h1-3,5-6H copy
InChIKey
OPZNJYOCOUQAQL-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
3 copy
Molar refractivity
44.25 copy
TPSA
49.57 copy
LogP / Solubility
WLOGP
1.5 copy
MLOGP
1.32 copy
XLogP3
1.3 copy
Consensus LogP
1.37 copy
Log S (ESOL)
-2.36 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.92 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.91 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.6 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy